Brain ‘pacemaker’ treats severe depression and anxiety in HALF of patients by correcting ‘bad brain signals’

A BRAIN ‘pacemaker’ has helped treat half of severely depressed or anxious patients by correcting ‘bad brain signals’.
The Malaysian Reserve

Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA® (valbenazine) Capsules

Published, peer-reviewed narrative review in CNS Spectrums compiles pharmacologic, pharmacokinetic and clinical data of VMAT2 inhibitors to highlight ...